| Date Filed | Type | Description |
| 06/08/2023 |
4
| Burbank Jeffrey H (Director) has filed a Form 4 on ARTIVION, INC.|
Txns:
| Granted 9,709 shares
@ $0 |
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 06/02/2020 |
4
| Burbank Jeffrey H (Director) has filed a Form 4 on CRYOLIFE INC|
Txns:
| Granted 5,667 shares
@ $22.94, valued at
$130k
|
|
| 05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2019 |
4
| Burbank Jeffrey H (Director) has filed a Form 4 on CRYOLIFE INC|
Txns:
| Granted 4,163 shares
@ $0 |
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2018 |
4
| Burbank Jeffrey H (Director) has filed a Form 4 on CRYOLIFE INC|
Txns:
| Granted 4,638 shares
@ $0 |
|
| 03/16/2018 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 28,039 shares
@ $24.05, valued at
$674.3k
Exercised 36,273 options to buy
@ $18.59, valued at
$674.3k
|
|
| 03/12/2018 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 5,167 shares
@ $24.37, valued at
$125.9k
Granted 52,392 restricted stock units
@ $0
Exercised 17,464 restricted stock units
@ $0 |
|
| 01/05/2018 |
3
| Burbank Jeffrey H (Director) has filed a Form 3 on CRYOLIFE INC |
| 04/21/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,000 shares
@ $27.28, valued at
$81.8k
|
|
| 04/20/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,000 shares
@ $26.65, valued at
$80k
|
|
| 03/23/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,000 shares
@ $27.42, valued at
$82.3k
|
|
| 03/22/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,000 shares
@ $27.72, valued at
$83.2k
|
|
| 03/13/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Granted 149,567 options to buy
@ $27.89, valued at
$4.2M
|
|
| 03/06/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 13,185 shares
@ $28.31, valued at
$373.3k
Exercised 28,022 restricted stock units
@ $0 |
|
| 02/24/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 7,500 shares
@ $28.97, valued at
$217.3k
|
|
| 02/23/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 7,500 shares
@ $29.01, valued at
$217.6k
|
|
| 02/14/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 49,555 shares
@ $28.38, valued at
$1.4M
Exercised 123,900 options to buy
@ $9.96, valued at
$1.2M
Exercised 3,697 options to buy
@ $18.48, valued at
$68.3k
Exercised 5,591 options to buy
@ $18.59, valued at
$103.9k
|
|
| 01/18/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 7,500 shares
@ $27.63, valued at
$207.2k
|
|
| 01/17/2017 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 7,500 shares
@ $27.52, valued at
$206.4k
|
|
| 12/14/2016 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 7,500 shares
@ $25.68, valued at
$192.6k
|
|
| 12/13/2016 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 7,500 shares
@ $25.42, valued at
$190.7k
|
|
| 11/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/10/2016 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Granted 268,159 options to buy
@ $15.58, valued at
$4.2M
|
|
| 03/07/2016 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 9,146 shares
@ $15.48, valued at
$141.6k
Exercised 28,021 restricted stock units
@ $0 |
|
| 03/06/2013 |
4
| Burbank Jeffrey H (President & CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Granted 27,017 shares
@ $0
Paid exercise price by delivering 12,103 shares
@ $11.03, valued at
$133.5k
Granted 30,320 restricted stock units
@ $0
Exercised 10,106 restricted stock units
@ $0
Granted 189,456 options to buy
@ $11.03, valued at
$2.1M
|
|
| 03/05/2013 |
4
| Burbank Jeffrey H (President & CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 3,274 shares
@ $11.05, valued at
$36.2k
|
|
| 01/11/2013 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 01/03/2013 |
4
| Burbank Jeffrey H (President & CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 14,916 shares
@ $11.25, valued at
$167.8k
Exercised 36,560 options to buy
@ $4.1, valued at
$149.9k
Exercised 35,768 restricted stock units
@ $0 |
|
|